LEGN
Legend Biotech Corporation
NASDAQ · Healthcare · Biotechnology · US
$21.57
−0.83%Forward multiples
Based on analyst estimates
- P/E forward
- 47.06x
- P/E 2026E
- —
- P/E 2027E
- 35.33x
- P/E 2028E
- 23.44x
- P/S forward
- 2.60x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.41x
- Price / sales
- 3.30x
- Price / cash flow
- -22.91x
Enterprise value
- Enterprise value
- $3.5B
- EV / sales
- 2.76x
- EV / EBITDA
- -484.36x
- EV / EBIT
- -62.48x
- Market cap
- $4.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026